Lumexa: What's In It and How It Works

Lumexa is Nolla’s clarifying daytime formula. It combines azelaic acid and niacinamide - two ingredients that are individually well-tolerated and, together, address acne, redness, and post-acne marks simultaneously. If this is your prescription, your clinician has likely identified that your skin needs an effective active that works without the irritation profile of stronger prescription ingredients.
What’s in Lumexa
Azelaic acid is a naturally occurring acid with a distinctive multi-action profile. It’s antibacterial, anti-inflammatory, and a tyrosinase inhibitor - meaning it blocks the enzyme responsible for melanin production, which directly reduces the formation and deepening of post-acne marks. This combination of properties in a single ingredient is rare. Prescription-strength azelaic acid is significantly more potent than over-the-counter concentrations.
Niacinamide complements azelaic acid by reinforcing the skin barrier, reducing additional inflammation, and further inhibiting the transfer of melanin between skin cells - adding a second layer of pigmentation control. It also regulates sebum production, which makes the formula useful for oily skin types prone to congestion.
What To Expect - and When
Weeks 1–2: Lumexa has a gentler adjustment profile than retinoid-based formulas. Some mild tingling or temporary redness immediately after application is normal, particularly in the first week. True purging is unlikely with azelaic acid.
Weeks 3–4: Active spots should begin to reduce. The anti-inflammatory effects of azelaic acid are typically among the earlier benefits to become visible - redness around existing breakouts tends to calm before the frequency of new breakouts decreases.
Weeks 6–10: Post-acne pigmentation and uneven skin tone are where azelaic acid’s longer-term benefit becomes clear. Consistent use in this window produces visible improvement in marks left by previous breakouts.
How To Use It
Lumexa is a daytime formula - apply it in the morning after cleansing and before moisturiser and SPF. Azelaic acid is stable in light, which makes it well suited to morning use.
- SPF every morning. Azelaic acid is targeting post-acne pigmentation - UV exposure actively stimulates further pigment production and undoes its work. SPF 30 minimum; SPF 50 if pigmentation is a primary concern.
- Tingling after application is normal. A mild stinging sensation that fades within a few minutes is a typical response to azelaic acid at prescription concentrations. Persistent burning is not normal - flag it through the app.
- It works well with other skincare. Azelaic acid and niacinamide are well tolerated alongside most ingredients. Avoid layering strong acids (AHAs/BHAs) directly on top in the same routine.
- Consistency matters for pigmentation. Improvements to post-acne marks take longer than improvements to active acne. Assess at eight to ten weeks, not four.
Who Lumexa Is Designed For
Lumexa is particularly well-suited to sensitive or reactive skin that needs an effective prescription active without the adjustment period of retinoids. It’s also an excellent fit where post-acne pigmentation is as much of a concern as the acne itself.
The Bottom Line
- Azelaic acid works on three levels: antibacterial, anti-inflammatory, and pigmentation-inhibiting, making Lumexa unusually comprehensive for a two-ingredient formula
- Niacinamide adds barrier support, additional inflammation control, and a second layer of pigmentation management
- The adjustment profile is gentler than retinoid-based formulas - mild tingling is normal, significant irritation is not
- SPF is essential if post-acne pigmentation is a concern
- Results on active acne appear in weeks 3–6; improvements to pigmentation become clear at weeks 8–10
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new skincare treatment, especially if you have underlying health conditions, are pregnant, or are taking medications.


